47.73.Z - Retail sale of pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
49.41.Z - Road freight transport
56.10.A - Food service activities
62.01.Z - Activities related to programming, IT consulting, and related activities
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,5 | 2,5 | 2,2 | -11,4 |
EBITDA | 2,5 | 2,5 | 2,3 | -9,6 |
Short time liabilities | 5,4 | 6,5 | 6 | -7,4 |
Equity capital | 3,7 | 3,7 | 3,5 | -7,5 |
Operating profit (EBIT) | 2,4 | 2,4 | 2,2 | -9,2 |
Assets | 9,3 | 10,2 | 9,4 | -7,4 |
Net profit (loss) | 2,5 | 2,5 | 2,2 | -11,4 |
Cash | 1 | 1,5 | 1,1 | -30,4 |
Liabilities and provisions for liabilities | 5,6 | 6,5 | 6 | -7,4 |
Net income from sale | 53,8 | 54,6 | 56,5 | 3,4 |
Working assets | 8,5 | 9,4 | 8,8 | -7 |
Depreciation | 0,1 | 0,1 | 0,1 | -17,6 |
% | % | % | p.p. | |
Profitability of capital | 65,7 | 65,9 | 63,1 | -2,8 |
Equity capital to total assets | 40 | 36,7 | 36,7 | 0 |
Gross profit margin | 4,6 | 4,5 | 3,9 | -0,6 |
EBITDA Margin | 4,6 | 4,6 | 4,1 | -0,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 36 | 43 | 39 | -4 |
Current financial liquidity indicator | 1.5747039318084717 | 1.4624738693237305 | 1.4680414199829102 | 0 |
Net dept to EBITDA | -0.33051401376724243 | -0.6036912202835083 | -0.4647798240184784 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane